financetom
Business
financetom
/
Business
/
Glaukos Launches Epioxa for Keratoconus Treatment
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Glaukos Launches Epioxa for Keratoconus Treatment
Mar 19, 2026 5:23 AM

07:54 AM EDT, 03/19/2026 (MT Newswires) -- Glaukos ( GKOS ) said Thursday it launched Epioxa for the treatment of keratoconus, a rare eye disease.

The drug is commercially available through direct ordering and the company's specialty pharmaceutical distribution network, Glaukos ( GKOS ) said.

Glaukos ( GKOS ) shares were down 0.9% in Thursday premarket trading.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved